NCT05562323 Characterization of Vaccine-induced Responses Against Monkeypox (MoVIHvax) An Observational Prospective Cohort Study
| NCT ID | NCT05562323 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia |
| Condition | Monkeypox |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2022-09-14 |
| Primary Completion | 2026-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2022-09-14 with a primary completion date of 2026-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This observational study has been designed to characterize humoral and cellular immune responses after vaccination against monkeypox (MKP) in HIV positive and negative individuals at high risk of MKP infection during the vaccination campaign in the current monkeypox outbreak.
Eligibility Criteria
Inclusion Criteria: 1. Adult individuals of ≥18 years old. 2. Willing to comply with the requirements of the protocol and available for follow-up for the planned duration of the trial. 3. Has understood the information provided and capable of giving informed consent. Exclusion Criteria: 1\. Participant has any medical condition and/or finding that in the investigator opinion might increase participant risks, interfere with the study or impair interpretation of study data.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05562323 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Monkeypox. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05562323 currently recruiting?
Yes, NCT05562323 is actively recruiting participants. Contact the research team at bmothe@irsicaixa.es for enrollment information.
Where is the NCT05562323 trial being conducted?
This trial is being conducted at Badalona, Spain, Barcelona, Spain, Barcelona, Spain.
Who is sponsoring the NCT05562323 clinical trial?
NCT05562323 is sponsored by Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia. The trial plans to enroll 100 participants.